Emily Ferris and Alex Arbuckle describe how using mint Lesion™ has enhanced their clinical trial operations, enabling “a more cooperative approach between [their] radiologists and oncologists” while simultaneously saving time and reducing costs.
Faced with a multitude of clinical trial site reads each day, Ms. Ferris and Mr. Arbuckle explain how they benefit from a more efficient workflow by using a dedicated software platform which provides a comprehensive and compliant response assessment and supports them in maintaining oversight of clinical trial imaging analysis design.
Ms. Ferris is a Lead Image Analyst and Mr. Arbuckle is a Clinical Research Imaging Core Manager at the University of Wisconsin Carbone Cancer Center.
Enhancing flexibility and communication while saving costs and time in clinical trials
Related Resources
NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion
Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of…
Read more
How Radiology Practices Can Participate in Germany’s Lung Cancer Screening Program with mint Lesion
New opportunities - but also economic uncertainty
With the launch of lung cancer screening (LCS) in Germany, radiology practices are facing a new…
Read more
Lung Cancer Screening in Germany: How mint Lesion Supports Hospitals with Infrastructure, Integration, and Scalability
Screening as a Strategic Challenge
With the launch of the national lung cancer screening program in 2026, hospitals and screening centers across…
Read more